← Back to Search

LED Light Therapy for Wound Healing

Waitlist Available
Led By Kristen Kelly, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 18 years or older with no active cutaneous disease on bilateral ventral biceps, close to the axilla.
Subjects shall have given written informed consent for both the LED therapy and for clinical photography.
Screening 3 weeks
Treatment Varies
Follow Up 56 days
Awards & highlights

Study Summary

This triallooks at how light therapy can help heal wounds after laser treatment. #LightTherapy #WoundHealing

Who is the study for?
This trial is for adults over 18 with no skin diseases near the underarm area who can consent to LED therapy and clinical photos. It's not for those on photosensitizing drugs, with epilepsy, cancer in the treatment area, using medications at the site, poor compliance risk, recent smokers, steroid users or those refusing consent.Check my eligibility
What is being tested?
The study tests Celluma POD light therapy's effectiveness on healing after laser treatments. Participants will receive combined red and near-infrared LED therapy to see how it helps tissue regeneration.See study design
What are the potential side effects?
Potential side effects may include skin irritation or increased sensitivity to light due to exposure from the LED device used during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am over 18 and have no skin disease near my underarms.
I have signed consent forms for LED therapy and clinical photos.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~56 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Days to healing
Secondary outcome measures
Pain level

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LED treatmentExperimental Treatment1 Intervention
LED treatment with Celluma POD device after laser test area
Group II: ControlActive Control1 Intervention
No treatment after laser test area

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
541 Previous Clinical Trials
1,921,860 Total Patients Enrolled
1 Trials studying Wound Healing
40 Patients Enrolled for Wound Healing
BioPhotasIndustry Sponsor
1 Previous Clinical Trials
42 Total Patients Enrolled
Kristen Kelly, MDPrincipal Investigator - University of California, Irvine
University of California-Irvine Medical Center
University Of California (Medical School)
University Ca Irvine Medical Center (Residency)
8 Previous Clinical Trials
405 Total Patients Enrolled

Media Library

Celluma POD Clinical Trial Eligibility Overview. Trial Name: NCT04834817 — N/A
Wound Healing Research Study Groups: LED treatment, Control
Wound Healing Clinical Trial 2023: Celluma POD Highlights & Side Effects. Trial Name: NCT04834817 — N/A
Celluma POD 2023 Treatment Timeline for Medical Study. Trial Name: NCT04834817 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being enlisted for this investigation?

"Clinicaltrials.gov data confirms that no participants are being recruited for this trial, which was posted on April 1 2021 and last updated November 2 2022. Nonetheless, 45 additional trials have open enrollment at the current moment in time."

Answered by AI
~7 spots leftby Apr 2025